Wednesday, July 8, 2026

pharma · Prostate Cancer · Autoimmune · JANX

Janux Therapeutics

Janux Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

San Diego, USA HQ
2017 Founded
110 Employees
Public company Type
JANX · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2017
Employees
110
Programs
4
Drugs
0
Patents
2
Intelligence · Clinical Programs

Janux Therapeutics projects

0 ClinicalTrials.gov programs sponsored by Janux Therapeutics.

Janux Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Janux Therapeutics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.